Columbia Research Enhanced Value ETF
REVS
1 hedge funds and large institutions have $307K invested in Columbia Research Enhanced Value ETF in 2020 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
5.53% less ownership
Funds ownership: 66.29% → 60.76% (-5.5%)
18% less capital invested
Capital invested by funds: $373K → $307K (-$66K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$32.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $307K | -$32.5K | -1,659 | -8% |
|
REVS Hedge Fund Activity: Q4 2020 in Review
1 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q4 2020, worth a combined $307K — down 18% from $373K a quarter earlier.
Fund positioning in REVS was balanced in Q4 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Jane Street, cutting an estimated $32.5K.
- 1 institutional investor held Columbia Research Enhanced Value ETF (REVS) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $307K of Columbia Research Enhanced Value ETF stock for Q4 2020, down 18% quarter-over-quarter.
- 0 funds opened new Columbia Research Enhanced Value ETF positions in Q4 2020 and 0 closed out.
- The largest Columbia Research Enhanced Value ETF seller in Q4 2020 was Jane Street, an estimated $32.5K sold.
Based on aggregated 13F filings for Q4 2020.